Navigation Links
Bio/Data Corporation Launches vW Select(TM) - The World's First and Only Complete Ristocetin CoFactor Assay
Date:6/30/2009

vW Select Significantly Reduces Laboratory Variability and Provides Clinicians with More Reliable Test Results

HORSHAM, Pa., June 30 /PRNewswire/ -- Today, Bio/Data Corporation announced the launch of vW Select(TM), the world's first all-in-one Ristocetin CoFactor Assay. vW Select is the first and only complete assay that measures the functional activity of the von Willebrand Factor. A deficiency of von Willebrand Factor causes von Willebrand Disease -- the world's most common bleeding disorder.

This new assay system includes all the reagents, control plasma, reference plasma, and diluents required to construct a standard reference curve and determine the Ristocetin Cofactor Activity in patient samples. Assay components are formulated, optimized and performance tested as a system to assure that linear standard reference curves are easy to achieve and test results are consistent, reliable and available quickly.

vW Select is manufactured, validated and performance tested under USFDA Quality System Regulations as well as the ISO 13485:2003 (Medical Device) Quality Management System Standard. This simplifies test Implementation and CLIA compliance, while eliminating the onerous regulatory mandates for homebrew or lab developed tests.

The analytical variability of existing Ristocetin Cofactor test systems is high -- 30%, and inter laboratory variability is about the same. Random combinations of Ristocetin reagents, general purpose control and reference plasmas, buffers and diluents are primary contributors to these variabilities. The matched components in each vW Select kit have been selected, tested and optimized to meet current published guidelines by improving overall assay system performance and reducing analytical variability.

vW Select addresses the clinical laboratory's need for a complete, accurate and cost effective test system for the detection, diagnosis and management of von Willebrand Disease.

For a limited time, Bio/Data Corporation is offering free samples of vW Select to qualified laboratories. Submit an online request for a free sample at www.biodatacorp.com, or contact Customer Service at Bio/Data Corporation.

vW Select is CE marked and is available worldwide from Bio/Data Corporation and its authorized distributors.

For 40 years, Bio/Data Corporation has been a leading manufacturer and worldwide distributor of products for clinical and research laboratories. Bio/Data Corporation is an ISO 9001:2000 and 13485:2003 registered company.

    FOR MORE INFORMATION PLEASE CONTACT:
    Kay Callahan
    Bio/Data Corporation
    215-441-4000
    1-800-257-3282
    215-443-8820 Fax
    www.biodatacorp.com


'/>"/>
SOURCE Bio/Data Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Environmental Tectonics Corporations BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting
2. Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan
3. Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St. John Wound Center
4. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
5. Guy J. Quigley Resigns as Chairman and CEO of The Quigley Corporation: Quigley Leaves Company He Founded 20 Years Ago
6. Techne Corporation Board Member Recognized
7. Mach One Corporation Developing a Nasal, Hand Carried Product as Solution to Swine Flu (H1N1) Virus
8. Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
9. Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
10. Techne Corporation Announces That John L. Higgins has Accepted a Seat on Technes Board
11. Onyx Pharmaceuticals Files Complaint Against Bayer Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... NextSteps 2017, ... North America this May on the following dates: , ?    London, UK ... Chairman of the Learning and Performance Institute will be the opening keynote ...
(Date:4/25/2017)... ... ... As part of the Stago EdVantage Virtual University Virtual Event, ... order to illuminate this clinical problem for people unfamiliar with the topic. , DIC ... high degree of morbidity and mortality. DIC is a confusing disorder from both diagnostic ...
(Date:4/25/2017)... , April 25, 2017 ... has licensed its novel immune-modulating technology to an undisclosed ... and allergy. Tregitopes, pronounced T·rej·itopes, are ... immunoglobulin by EpiVax CEO Annie De Groot ... intravenous immunoglobulin G, an autoimmune disease therapy, Tregitopes ...
(Date:4/25/2017)... ... 2017 , ... Leaders of Quorum Review IRB and Kinetiq ... at this week’s Association of Clinical Research Professionals (ACRP) 2017 Meeting & Expo ... , "We are excited to present subject matter expertise on topics that impact the ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):